Phase III study: patients with most common type of lung cancer lived longer with ALIMTA-based continuation maintenance therapy
4 June 2012 | By Eli Lilly and Company
Overall survival data from PARAMOUNT study submitted to FDA...
List view / Grid view
News
Lung cancer study showed encouraging results for ALIMTA-based regimens and full-dose radiation
4 June 2012 | By Eli Lilly and Company
Eli Lilly and Company announced results of a Phase II trial evaluating ALIMTA®...
Afatinib* delivers unprecedented first line efficacy in patients with EGFR mutation positive lung cancer in registration trial
4 June 2012 | By Boehringer Ingelheim
LUX-Lung 3 results highlighted at the official ASCO Press Conference...
resDNASEQ® E. coli Residual DNA Quantitation System
1 June 2012 | By Life Technologies
Integrated sample preparation and real-time PCR assay for the quantitation of E. coli host cell DNA...
Beat In-Albon new COO of the life science ingredients sector
Starting on 1 June 2012, Beat In-Albon will join Lonza as COO of the Life Science Ingredients Sector and become a member of the Management Committee, replacing Harry Boot. Beat In-Albon brings broad industry experience to his role, having worked for Lonza already from 1983-2006, where he was Head of…
GSK announces expiration of Hart-Scott-Rodino waiting period for tender offer for HGS
1 June 2012 | By GlaxoSmithKline
GSK has clearance under the U.S. anti-trust laws to acquire HGS...
Boehringer Ingelheim launches first-of-a-kind fundraising model to support disease awareness projects
1 June 2012 | By Boehringer Ingelheim
Boehringer Ingelheim announces a new partnership with ammado...
Catalent enters agreement to sell its U.S. commercial packaging operations
31 May 2012 | By Catalent Pharma Solutions
Catalent signed a definitive agreement to sell its U.S. commercial packaging operations based in Philadelphia, PA and Woodstock, IL...
Phenomenex streamlines access to applications library with unique structure search capability
31 May 2012 | By Phenomenex
Phenomenex Inc., announces unique new Structure Search functionality...
Novartis showcases ongoing research at ASCO to help patients fight various cancers
31 May 2012 | By Novartis
Novartis will showcase the clinical progress of multiple marketed and pipeline compounds...
New data showed LIVALO® (pitavastatin) met primary endpoint of LDL-C reduction when compared with pravastatin
31 May 2012 | By Eli Lilly and Company
Results of the PREVAIL U.S. study...
Boehringer Ingelheim expands development capacities with new technical centre
31 May 2012 | By Boehringer Ingelheim
Boehringer Ingelheim is establishing a new 50 million-plus euro pilot plant facility...
GSK announces submissions in the EU & US for new indications for Promacta®/Revolade®
30 May 2012 | By GlaxoSmithKline
GlaxoSmithKline has submitted regulatory applications in the European Union and US...
Lilly’s commitment to global innovation reinforced with opening of new diabetes-focused research and development center in Shanghai
30 May 2012 | By Eli Lilly and Company
Eli Lilly & Company opened the LCRDC...
Biogen Idec continues support for MS community with worldwide celebrations on Fourth Annual World MS Day
30 May 2012 | By Biogen Idec
Biogen Idec will join with the MS community around the world...
